PURPOSE: Disease symptom management in patients with advanced non-small cell lung cancer (NSCLC) is a critical aspect of therapy. The main objective of our study was to assess patient-reported outcomes and the degree of concordance between physician and patient perceptions of symptom severity in advanced NSCLC in the USA. METHODS: Patients with advanced (stage IIIB/IV) NSCLC (N = 450) were recruited in a nationwide (USA) lung cancer study. Patients and their oncologists completed patient and physician versions of the Lung Cancer Symptom Scale (LCSS). Patient-reported lung cancer-specific quality of life was assessed with the Functional Assessment of Cancer Therapy--Lung (FACT-L). Concordance was assessed using the kappa-statistic. Regression analysis was performed with FACT-L total score as the dependent variable and patient-reported LCSS symptom scores as predictors. RESULTS: A high proportion of patients experienced lung cancer symptoms: fatigue (100 %), loss of appetite (97 %), shortness of breath (95 %), cough (93 %), pain (92 %), and blood in sputum (63 %). Concordance between physician and patients was lowest for loss of appetite (kappa 0.1701) and greatest for hemoptysis (kappa 0.4586). Loss of appetite (β = -0.204; p < 0.001), cough (β = -0.145; p < 0.01), pain (β = -0.265; p < 0.001), and shortness of breath (β = -0.145; p < 0.01) were found to be significant predictors of the quality of life. CONCLUSIONS: Symptom burden in patients with advanced NSCLC is high and has a negative impact on the quality of life. Patient-reported outcomes data could help optimize disease outcomes and therapy management in NSCLC.
PURPOSE: Disease symptom management in patients with advanced non-small cell lung cancer (NSCLC) is a critical aspect of therapy. The main objective of our study was to assess patient-reported outcomes and the degree of concordance between physician and patient perceptions of symptom severity in advanced NSCLC in the USA. METHODS:Patients with advanced (stage IIIB/IV) NSCLC (N = 450) were recruited in a nationwide (USA) lung cancer study. Patients and their oncologists completed patient and physician versions of the Lung Cancer Symptom Scale (LCSS). Patient-reported lung cancer-specific quality of life was assessed with the Functional Assessment of Cancer Therapy--Lung (FACT-L). Concordance was assessed using the kappa-statistic. Regression analysis was performed with FACT-L total score as the dependent variable and patient-reported LCSS symptom scores as predictors. RESULTS: A high proportion of patients experienced lung cancer symptoms: fatigue (100 %), loss of appetite (97 %), shortness of breath (95 %), cough (93 %), pain (92 %), and blood in sputum (63 %). Concordance between physician and patients was lowest for loss of appetite (kappa 0.1701) and greatest for hemoptysis (kappa 0.4586). Loss of appetite (β = -0.204; p < 0.001), cough (β = -0.145; p < 0.01), pain (β = -0.265; p < 0.001), and shortness of breath (β = -0.145; p < 0.01) were found to be significant predictors of the quality of life. CONCLUSIONS: Symptom burden in patients with advanced NSCLC is high and has a negative impact on the quality of life. Patient-reported outcomes data could help optimize disease outcomes and therapy management in NSCLC.
Authors: John F P Bridges; Ateesha F Mohamed; Henrik W Finnern; Anette Woehl; A Brett Hauber Journal: Lung Cancer Date: 2012-02-25 Impact factor: 5.705
Authors: Chantal Quinten; John Maringwa; Carolyn C Gotay; Francesca Martinelli; Corneel Coens; Bryce B Reeve; Henning Flechtner; Eva Greimel; Madeleine King; David Osoba; Charles Cleeland; Jolie Ringash; Joseph Schmucker-Von Koch; Martin J B Taphoorn; Joachim Weis; Andrew Bottomley Journal: J Natl Cancer Inst Date: 2011-12-07 Impact factor: 13.506
Authors: Marie Flannery; Karen F Stein; David W Dougherty; Supriya Mohile; Joseph Guido; Nancy Wells Journal: Oncol Nurs Forum Date: 2018-09-01 Impact factor: 2.172
Authors: Catherine E Mosher; Joseph G Winger; Nasser Hanna; Shadia I Jalal; Lawrence H Einhorn; Thomas J Birdas; DuyKhanh P Ceppa; Kenneth A Kesler; Jordan Schmitt; Deborah A Kashy; Victoria L Champion Journal: J Pain Symptom Manage Date: 2016-07-09 Impact factor: 3.612
Authors: Kelly M Kenzik; Patricia A Ganz; Michelle Y Martin; Laura Petersen; Ron D Hays; Neeraj Arora; Maria Pisu Journal: Cancer Date: 2015-04-17 Impact factor: 6.860
Authors: Seyyed Mohammad Reza Kazemi-Bajestani; Harald Becher; Charles Butts; Naveen S Basappa; Michael Smylie; Anil Abraham Joy; Randeep Sangha; Andrea Gallivan; Quincy Chu; Vickie E Baracos Journal: Support Care Cancer Date: 2018-12-13 Impact factor: 3.603